Further processing options
Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer
Saved in:
Journal Title: | Clinical Cancer Research |
---|---|
Authors and Corporations: | , , , , , , , , , , , |
In: | Clinical Cancer Research, 19, 2013, 1, p. 170-182 |
Type of Resource: | E-Article |
Language: | English |
published: |
American Association for Cancer Research (AACR)
|
Subjects: |